We recommend that workers in the field of cardiac disease take a greater interest in both VWF and ADAMTS13 [21], to both identify the opposing risks of bleeding and thrombosis, and to potentially consider supportive therapies or curative approaches, as the case may require. The gene discussed is ADAMTS13; the disease is heart disorder.